These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 24275343)

  • 1. Update on biomarkers of hepatocellular carcinoma.
    Chaiteerakij R; Addissie BD; Roberts LR
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):237-45. PubMed ID: 24275343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers for the Early Detection of Hepatocellular Carcinoma.
    Parikh ND; Mehta AS; Singal AG; Block T; Marrero JA; Lok AS
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2495-2503. PubMed ID: 32238405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Tumor Biomarkers in the Surveillance of Hepatocellular Carcinoma.
    Lim YS
    Korean J Gastroenterol; 2021 Nov; 78(5):284-288. PubMed ID: 34824186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
    Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
    Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage.
    Luo P; Wu S; Yu Y; Ming X; Li S; Zuo X; Tu J
    Pathol Oncol Res; 2020 Apr; 26(2):599-603. PubMed ID: 30661224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The predictive powers of plasma trefoil factor 3 or its related micro RNAs for patients with hepatocellular carcinoma.
    Zhang C; Xia R; Zhang B; Wang H
    BMC Cancer; 2018 Nov; 18(1):1110. PubMed ID: 30424721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCC and Tumor Biomarkers: Does One Size Fits All?
    Ozgor D; Otan E
    J Gastrointest Cancer; 2020 Dec; 51(4):1122-1126. PubMed ID: 32827068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extracellular mRNA detected by molecular beacons in tethered lipoplex nanoparticles for diagnosis of human hepatocellular carcinoma.
    Wang X; Kwak KJ; Yang Z; Zhang A; Zhang X; Sullivan R; Lin D; Lee RL; Castro C; Ghoshal K; Schmidt C; Lee LJ
    PLoS One; 2018; 13(6):e0198552. PubMed ID: 29879168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biomarkers in hepatocellular carcinoma.
    De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
    Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Large-scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma.
    Luo P; Yin P; Hua R; Tan Y; Li Z; Qiu G; Yin Z; Xie X; Wang X; Chen W; Zhou L; Wang X; Li Y; Chen H; Gao L; Lu X; Wu T; Wang H; Niu J; Xu G
    Hepatology; 2018 Feb; 67(2):662-675. PubMed ID: 28960374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies in surveillance and early diagnosis of hepatocellular carcinoma.
    Kim DY; Kim JW; Kuromatsu R; Ahn SH; Torimura T; Sherman M
    Oncology; 2011; 81 Suppl 1():56-60. PubMed ID: 22212937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Power of metabolomics in diagnosis and biomarker discovery of hepatocellular carcinoma.
    Wang X; Zhang A; Sun H
    Hepatology; 2013 May; 57(5):2072-7. PubMed ID: 23150189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal assessment of alpha-fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis.
    Kim MN; Kim BK; Kim SU; Park JY; Ahn SH; Han KH; Kim DY
    Scand J Gastroenterol; 2019 Oct; 54(10):1283-1290. PubMed ID: 31593481
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current Practice of Hepatocellular Carcinoma Surveillance.
    Loho IM; Siregar L; Waspodo AS; Hasan I
    Acta Med Indones; 2018 Oct; 50(4):353-360. PubMed ID: 30631003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced detection of early hepatocellular carcinoma by serum SELDI-TOF proteomic signature combined with alpha-fetoprotein marker.
    Chen L; Ho DW; Lee NP; Sun S; Lam B; Wong KF; Yi X; Lau GK; Ng EW; Poon TC; Lai PB; Cai Z; Peng J; Leng X; Poon RT; Luk JM
    Ann Surg Oncol; 2010 Sep; 17(9):2518-25. PubMed ID: 20354800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
    Saad ZM; Fouad Y; Ali LH; Hassanin TM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.